Epidemiology and Burden of Antimicrobial Resistance
This area studies how resistance to antimicrobial agents arises in microbial populations, how resistant organisms spread between hosts and across settings, how they are tracked through surveillance, and how much harm they cause to populations and health systems. It applies the tools of epidemiology to a microbiological problem, asking not only why an organism is resistant but where, how often, and with what consequence resistance occurs.
Definition
The epidemiology and burden of antimicrobial resistance is the study of the distribution, determinants, and population-level consequences of antimicrobial-resistant organisms, encompassing their emergence and selection, their transmission, their surveillance, and the estimation of their morbidity, mortality, and economic impact.
Scope
The area orients the reader to four linked questions: how resistant organisms emerge and are selected, how they are transmitted in healthcare and community settings, how surveillance systems measure resistance, and how the resulting burden is quantified in morbidity, mortality, and cost. It frames antimicrobial resistance as a population-level phenomenon and serves as the epidemiological complement to the mechanistic and stewardship topics elsewhere in the antimicrobial-resistance subfield.
Sub-topics
Core questions
- How do resistant organisms emerge and become selected within microbial populations?
- By what routes do resistant organisms spread in hospitals and in the community?
- How is resistance measured and tracked across laboratories, countries, and time?
- How large is the human and economic burden attributable to antimicrobial resistance?
Key concepts
- Selection pressure from antimicrobial use
- Horizontal gene transfer and mobile genetic elements
- Colonization versus infection
- Reservoirs and transmission routes
- Resistance surveillance and antibiograms
- Attributable mortality and disability-adjusted life-years
- One Health framing across human, animal, and environmental compartments
Mechanisms
Resistance becomes an epidemiological problem through the interplay of selection and spread. Exposure to antimicrobials, including subinhibitory concentrations, favours organisms that carry or acquire resistance determinants, while mobile genetic elements allow those determinants to move between strains and species. Selected organisms then disseminate through contact, contaminated environments, food chains, and movement of colonized people, so that local selection events can become regional or global problems. Surveillance measures the resulting frequency of resistance, and burden estimation translates that frequency into counts of deaths, illness, and cost.
Clinical relevance
Understanding the epidemiology and burden of resistance underpins infection prevention, empirical-therapy decisions at the population level, and policy on antimicrobial use, but this area describes how resistance is distributed and quantified rather than offering individual treatment guidance. It explains why local resistance patterns matter for clinical reasoning and why surveillance data inform institutional and national responses.
Epidemiology
Antimicrobial resistance is a global phenomenon with marked geographic and pathogen-specific variation. Modelling work attributes a large and rising number of deaths to bacterial resistance worldwide, with the heaviest burden in regions with limited diagnostic and stewardship capacity, and concentrated among a small set of priority pathogens. The drivers span human medicine, agriculture, and the environment, motivating a One Health approach to measurement and control.
History
Resistance was observed soon after antimicrobials entered clinical use in the mid-twentieth century, but its framing as a measurable population burden matured later, as national and international surveillance systems were built and as modelling studies began to estimate attributable mortality. International policy crystallized around coordinated action plans that placed surveillance and burden estimation at the centre of the response.
Related topics
Seminal works
- murray-2022
- holmes-2016
- laxminarayan-2013
Frequently asked questions
- How does this area differ from the mechanisms of resistance?
- Mechanistic topics explain how a single organism resists a drug at the molecular level; this area studies resistance as a population phenomenon — how often it occurs, how it spreads, how it is tracked, and how much harm it causes.
- Why is antimicrobial resistance described using a One Health framing?
- Because resistance moves between human, animal, and environmental compartments, its emergence, transmission, and burden cannot be fully understood or measured within human medicine alone.